Literature DB >> 23177332

Evaluation of hepatic metabolic activity in non-alcoholic fatty livers on 18FDG PET/CT.

Z Dostbil1, E Varoğlu, M Serdengeçti, B Kaya, H Onder, O Sari.   

Abstract

OBJECTIVE: The liver has been used as a reference organ for the assessment of abnormal (18)F-fluoro-2-deoxy-d-glucose ((18)FDG) in the body. Some researchers found that hepatosteatosis significantly changed the hepatic (18)FDG uptake, while others did not. This study investigated whether the liver's (18)FDG uptake was affected by the diffuse fatty infiltration of the liver.
MATERIAL AND METHODS: A total of 156 cases were included in this study. Different patient groups were defined according to the liver Hounsfield unit (HU). The HU was calculated from an unenhanced CT, for all patients, and we calculated the mean standardized uptake value (SUVmean) and maximum standardized uptake value (SUVmax) on an (18)FDG PET scan. For this purpose, we placed regions of interest (ROIs) on the liver image. We statistically compared the SUVmean and SUVmax measured in the fatty liver patients and the control group.
RESULTS: The average SUVmean and SUVmax values were calculated as 2.58±0.66 and 3.94±1, respectively, in the patient group and 2.54±0.57 and 3.7±0.88, respectively, in the control group. We found the average SUVmean and SUVmax values in the fatty liver group and its subsets were not significantly different from the values in the control group (p>0.05). We also did not find any statistically significant correlation between average liver density (HU) and the average SUV values (p>0.05).
CONCLUSION: Fatty infiltration may not have a significant effect on the liver's (18)FDG uptake. Thus, the liver may be used as a reference or comparator on (18)FDG PET scans in patients with fatty liver disease.
Copyright © 2012 Elsevier España, S.L. and SEMNIM. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177332     DOI: 10.1016/j.remn.2012.04.006

Source DB:  PubMed          Journal:  Rev Esp Med Nucl Imagen Mol        ISSN: 2253-654X            Impact factor:   1.359


  5 in total

1.  Mean standardized uptake value (SUVmean) and global hepatic glycolysis as potential imaging markers reflecting hepatic functional capacity: evidence from 18F-FDG PET/CT.

Authors:  X Yue; J Wang; F Ye; D Xiao
Journal:  Hippokratia       Date:  2018 Oct-Dec       Impact factor: 0.471

2.  Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.

Authors:  Sun-pyo Hong; Tae Soo Noh; Seung-Hwan Moon; Young Seok Cho; Eun Jeong Lee; Joon Young Choi; Byung-Tae Kim; Kyung-Han Lee
Journal:  Dig Dis Sci       Date:  2013-12-11       Impact factor: 3.199

3.  In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by 18F-FDG PET/CT.

Authors:  Niklas Verloh; Ingo Einspieler; Kirsten Utpatel; Karin Menhart; Stefan Brunner; Frank Hofheinz; Jörg van den Hoff; Philipp Wiggermann; Matthias Evert; Christian Stroszczynski; Dirk Hellwig; Jirka Grosse
Journal:  EJNMMI Res       Date:  2018-11-09       Impact factor: 3.138

Review 4.  PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease.

Authors:  Tuo Shao; Lee Josephson; Steven H Liang
Journal:  Mol Imaging       Date:  2019 Jan-Dec       Impact factor: 4.488

5.  Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study.

Authors:  Zhong-Wei Chen; Kun Tang; You-Fan Zhao; Yang-Zong Chen; Liang-Jie Tang; Gang Li; Ou-Yang Huang; Xiao-Dong Wang; Giovanni Targher; Christopher D Byrne; Xiang-Wu Zheng; Ming-Hua Zheng
Journal:  Int J Med Sci       Date:  2021-09-07       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.